Blood Cancer Discovery

Blood Cancer Discovery is a peer-reviewed medical journal published by the American Association for Cancer Research, launched in 2020 and devoted to leukemia, lymphoma and myeloma research, with a 2025 Journal Impact Factor of 12.2（Blood Cancer Discovery）是由（American Association for Cancer Research）出版的同行评审医学期刊，2020 年创刊，聚焦白血病、淋巴瘤与骨髓瘤研究，2025 年影响因子为 12.2。

Scope

• It publishes research articles and briefs reporting major advances in basic, translational and clinical research on leukemia, lymphoma, myeloma and associated diseases该刊发表报道白血病、淋巴瘤、骨髓瘤及相关疾病的基础、转化与临床研究重大进展的研究论文与简报。^[1]
• Covered topics include the molecular and cellular features of pathogenesis and of therapy response and relapse涵盖议题包括发病机制以及治疗应答与复发的分子与细胞特征。
• They also include transcriptional circuits, stem cells, differentiation, the microenvironment, metabolism, immunity, mutagenesis and clonal evolution还包括转录环路、干细胞、分化、微环境、代谢、免疫、突变发生与克隆演化。
• It welcomes submissions on new pharmacological, biological and living cell therapies该刊欢迎关于新型药理、生物与活细胞疗法的投稿。^[2]
• It covers new diagnostic tools and prognostic, diagnostic and pharmacodynamic biomarkers涵盖新型诊断工具以及预后、诊断与药效生物标志物。
• It also covers computational and machine learning approaches to personalized medicine, from preclinical proof of concept to clinical trials还涵盖面向个体化医疗的计算与机器学习方法，从临床前概念验证到临床试验。
• It publishes reviews, perspectives and commentaries on topics of broad interest in hematooncology该刊发表血液肿瘤学中广受关注议题的综述、视角与评论。

History

• It was launched in 2020 by the American Association for Cancer Research该刊由（American Association for Cancer Research）于 2020 年创办。
• It is published bimonthly with one volume per year by the AACR该刊由（AACR）双月刊出版，每年一卷。
• It is indexed in the Emerging Sources Citation Index该刊被（Emerging Sources Citation Index）收录。
• It received an inaugural Journal Impact Factor of 11.4 in 2023该刊 2023 年获得首个影响因子 11.4。
• Its Journal Impact Factor was 11.5 in 2024 and 12.2 in 2025其影响因子 2024 年为 11.5，2025 年为 12.2。
• It belongs to the AACR journal portfolio and offers both subscription and open access publishing该刊属于（AACR）期刊群，提供订阅与开放获取两种出版方式。

Editors

• Its editors-in-chief are Ross L. Levine, Riccardo Dalla-Favera and Kenneth C. Anderson其主编为（Ross L. Levine）、（Riccardo Dalla-Favera）与（Kenneth C. Anderson）。
• Its scientific editors include Ash A. Alizadeh and Scott A. Armstrong其科学编辑包括（Ash A. Alizadeh）与（Scott A. Armstrong）。
• They also include John E. Dick and Carl H. June还包括（John E. Dick）与（Carl H. June）。
• They further include Elaine S. Jaffe, John C. Byrd and Margaret A. Goodell还包括（Elaine S. Jaffe）、（John C. Byrd）与（Margaret A. Goodell）。
• Other scientific editors include Hagop M. Kantarjian and Charles G. Mullighan其他科学编辑包括（Hagop M. Kantarjian）与（Charles G. Mullighan）。
• Its scientific editors also include Michel W. Sadelain and Catherine J. Wu其科学编辑还包括（Michel W. Sadelain）与（Catherine J. Wu）。
• Its deputy editor is Tanya Bondar of the AACR editorial office in Philadelphia其副编辑为（Tanya Bondar），任职于（AACR）位于费城的编辑部。